Revenue vs Net income
Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.
Margin trend
Gross, operating and net margin. Margins are derived from reported dollars.
Revenue YoY growth
Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).
Income statement
From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.6B | $4.7B | $5.1B | $5.1B | $5.3B | $5.2B | $5.4B |
| YoY | — | — | — | — | +20.3% | +15.9% | +11.6% | +7.5% |
| Cost of goods sold | $1.3B | $1.5B | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B | $1.6B |
| YoY | — | — | — | — | +16.1% | +9.7% | +9.4% | -2.6% |
| Gross profit | $2.9B | $3.1B | $3.2B | $3.4B | $3.5B | $3.7B | $3.6B | $3.8B |
| YoY | — | — | — | — | +22.3% | +18.9% | +12.6% | +12.4% |
| Research & development | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Selling, general & administrative | $1.6B | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | $1.8B | $1.8B |
| YoY | — | — | — | — | +11.5% | +13.8% | +11.5% | +5.1% |
| Operating income | $733.0M | $675.0M | $921.0M | $819.0M | $1.0B | $825.0M | $1.1B | $1.2B |
| YoY | — | — | — | — | +43.0% | +22.2% | +19.5% | +43.8% |
| Pretax income | $669.0M | $585.0M | $805.0M | $941.0M | $939.0M | $700.0M | $1.2B | $1.1B |
| YoY | — | — | — | — | +40.4% | +19.7% | +44.3% | +12.6% |
| Income tax | $200.0M | $23.0M | $133.0M | $146.0M | $183.0M | $30.0M | $-176.0M | $155.0M |
| YoY | — | — | — | — | -8.5% | +30.4% | -232.3% | +6.2% |
| Net income | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| EPS — basic | $0.32 | — | $0.46 | $0.54 | $0.51 | — | $0.90 | $0.62 |
| YoY | — | — | — | — | +59.4% | — | +95.7% | +14.8% |
| EPS — diluted | $0.32 | — | $0.45 | $0.53 | $0.51 | — | $0.90 | $0.61 |
| YoY | — | — | — | — | +59.4% | — | +100.0% | +15.1% |
| Weighted shares — basic | 1.47B | — | 1.48B | 1.48B | 1.48B | — | 1.48B | 1.47B |
| Weighted shares — diluted | 1.49B | — | 1.49B | 1.49B | 1.50B | — | 1.50B | 1.47B |
Balance sheet
Point-in-time values at each quarter (or fiscal year) end.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.5B | $414.0M | $725.0M | $534.0M | $1.3B | $2.0B | $1.5B | $539.0M |
| YoY | — | — | — | — | -49.0% | +374.6% | +100.4% | +0.9% |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Inventory | $2.8B | $2.8B | $2.9B | $2.9B | $2.9B | $2.9B | $3.1B | $3.2B |
| YoY | — | — | — | — | +6.1% | +4.7% | +8.7% | +13.1% |
| Total current assets | $8.8B | $6.9B | $7.3B | $7.1B | $8.0B | $8.8B | $8.7B | $8.0B |
| YoY | — | — | — | — | -8.3% | +27.1% | +18.4% | +12.0% |
| Total assets | $38.1B | $39.4B | $40.1B | $41.6B | $42.7B | $43.7B | $44.4B | $45.2B |
| YoY | — | — | — | — | +12.2% | +10.9% | +10.5% | +8.8% |
| Total current liabilities | $5.9B | $6.4B | $5.1B | $5.2B | $5.3B | $5.4B | $4.6B | $6.4B |
| YoY | — | — | — | — | -9.8% | -15.0% | -9.6% | +23.9% |
| Total liabilities | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Total equity | $20.7B | $21.8B | $22.2B | $22.4B | $23.4B | $24.2B | $25.9B | $24.9B |
| YoY | — | — | — | — | +13.0% | +11.3% | +16.4% | +11.2% |
| Shares outstanding | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
Cash flow
Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.0B | $1.5B | $541.0M | $1.3B | $1.3B | $1.4B | $348.0M | $1.5B |
| YoY | — | — | — | — | +34.0% | -6.3% | -35.7% | +14.6% |
| Capital expenditures | $179.0M | $277.0M | $187.0M | $157.0M | $181.0M | $351.0M | $177.0M | $195.0M |
| YoY | — | — | — | — | +1.1% | +26.7% | -5.3% | +24.2% |
| Free cash flow | $823.0M | $1.2B | $354.0M | $1.1B | $1.2B | $1.0B | $171.0M | $1.3B |
| YoY | — | — | — | — | +41.2% | -14.1% | -51.7% | +13.3% |
| Dividends paid | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | $0 | — | — | — | $2.0B |
| YoY | — | — | — | — | — | — | — | — |
Margins & ratios
Derived from the reported dollars above — no separate source.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 68.8% | 67.9% | 68.8% | 67.7% | 69.9% | 69.6% | 69.5% | 70.7% |
| Operating margin | 17.4% | 14.8% | 19.8% | 16.2% | 20.7% | 15.6% | 21.2% | 21.6% |
| Net margin | — | — | — | — | — | — | — | — |
| Free cash flow margin | 19.6% | 25.8% | 7.6% | 22.3% | 22.9% | 19.2% | 3.3% | 23.5% |
| Effective tax rate | 29.9% | 3.9% | 16.5% | 15.5% | 19.5% | 4.3% | -15.1% | 14.6% |
| Current ratio | 1.48x | 1.08x | 1.45x | 1.37x | 1.51x | 1.62x | 1.90x | 1.24x |
| Total liabilities / equity | — | — | — | — | — | — | — | — |
Peer comparison — latest full year
Same sector (Health Care), sorted by revenue. All figures from the same EDGAR XBRL snapshot.
| Ticker | Revenue | Revenue YoY | Gross margin | Operating margin | Net margin | FCF margin |
|---|---|---|---|---|---|---|
| BSX FY16 · this stock | $8.4B | — | 71.1% | 5.3% | — | 9.6% |
| UNH FY25 | $447.6B | +11.8% | — | 4.2% | 2.7% | 3.6% |
| CVS FY25 | $402.1B | +7.8% | — | 1.2% | 0.4% | 1.9% |
| CI FY25 | $274.9B | +11.2% | — | 3.3% | — | — |
| ELV FY25 | $199.1B | +12.5% | — | 3.6% | 2.8% | 1.6% |
| JNJ FY25 | $94.2B | +6.0% | 67.9% | — | 28.5% | 20.9% |
| LLY FY25 | $65.2B | +44.7% | — | — | 31.7% | — |
| MRK FY25 | $65.0B | +1.3% | — | — | 28.1% | 19.0% |
| ABBV FY25 | $61.2B | +8.6% | — | 24.6% | 6.9% | 29.1% |
| BMY FY25 | $48.2B | -0.2% | — | — | 14.6% | 26.7% |
| TMO FY25 | $44.6B | +3.9% | — | 17.4% | 15.0% | 14.1% |
Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.